Its anti‐inflammatory properties suppress microglial and astrocyte activation, inhibit NF‐κB signaling, and lower pro‐inflammatory cytokines such as IL‐1β and TNF‐α, thereby alleviating chronic neuroinflammation that exacerbates AD pathology (McGrattan et al. 2019). The gene discussed is NFKB1; the disease is Alzheimer disease.